Zobrazeno 1 - 3
of 3
pro vyhledávání: '"MESH: Pneumocystis carinii"'
Autor:
Tedbirt, Billal, Duval-Modeste, Anne-Benedicte, Courville, Philippe, Dominique, Stéphane, Vera, Pierre, Regaieg, Hamza
Publikováno v:
Clinical Nuclear Medicine
Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2021, 46 (4), pp.e210-e211. ⟨10.1097/RLU.0000000000003420⟩
Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2021, 46 (4), pp.e210-e211. ⟨10.1097/RLU.0000000000003420⟩
International audience; A 56-year-old woman, with history of psoriasis well controlled on ustekinumab, underwent 18F-FDG PET/CT to explore first onset of histologically proven skin panniculitis of unknown origin. PET/CT showed high uptake in pannicul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::91be725078980615edd378ceb7ba4366
https://hal.archives-ouvertes.fr/hal-03226501
https://hal.archives-ouvertes.fr/hal-03226501
Autor:
Damien Dupont, Marta Kicia, Willem J. G. Melchers, Nicolas Guigue, Alexandre Alanio, Stéphane Bretagne, Olga Matos, Anne Totet, Florent Morio, Maud Gits-Muselli, Enrique J. Calderón, Jannik Helweg-Larsen, David Di Cave, Axel Hamprecht, Martina Lengerová, Gilles Nevez, Katrien Lagrou, Philippe M. Hauser, Marie Desnos-Ollivier, Lewis P. White
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
EBioMedicine
EBioMedicine, Elsevier, 2017, 22, pp.155-163. ⟨10.1016/j.ebiom.2017.06.027⟩
EBioMedicine, 2017, 22, pp.155-163. ⟨10.1016/j.ebiom.2017.06.027⟩
Ebiomedicine, 22, 155-163
EBioMedicine, vol. 22, pp. 155-163
Ebiomedicine, 22, pp. 155-163
EBioMedicine, Vol 22, Iss C, Pp 155-163 (2017)
instname
EBioMedicine
EBioMedicine, Elsevier, 2017, 22, pp.155-163. ⟨10.1016/j.ebiom.2017.06.027⟩
EBioMedicine, 2017, 22, pp.155-163. ⟨10.1016/j.ebiom.2017.06.027⟩
Ebiomedicine, 22, 155-163
EBioMedicine, vol. 22, pp. 155-163
Ebiomedicine, 22, pp. 155-163
EBioMedicine, Vol 22, Iss C, Pp 155-163 (2017)
Pneumocystis jirovecii is an airborne human-specific ascomycetous fungus responsible for Pneumocystis pneumonia (PCP) in immunocompromised patients, affecting > 500,000 patients per year (www.gaffi.org). The understanding of its epidemiology is limit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f1a21ac98adbf77d92d416d04af4d2a
http://hdl.handle.net/10261/180281
http://hdl.handle.net/10261/180281
Autor:
Julia Salleron, Emilie Fréalle, Benoit Wallaert, Francisca Hernández-Hernández, Patrick Caneiro, Eduardo Dei-Cas, Isabelle Accoceberry, Laurence Delhaes, Jean-Philippe Bouchara, Isabelle Durand-Joly
Publikováno v:
Journal of Clinical Microbiology
Journal of Clinical Microbiology, 2012, 50 (12), pp.4107-4110. ⟨10.1128/JCM.01974-12⟩
Journal of Clinical Microbiology, American Society for Microbiology, 2012, 50 (12), pp.4107-4110. ⟨10.1128/JCM.01974-12⟩
Journal of Clinical Microbiology, 2012, 50 (12), pp.4107-4110. ⟨10.1128/JCM.01974-12⟩
Journal of Clinical Microbiology, American Society for Microbiology, 2012, 50 (12), pp.4107-4110. ⟨10.1128/JCM.01974-12⟩
Pneumocystis carriage was detected in 12.5% of 104 cystic fibrosis (CF) patients during a prospective multicenter French study, with a prevalence of genotype 85C/248C and geographic variations. It was significantly associated with the absence of Pseu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::539d6688f57b98a4ce8bdcdabcbf629d
https://univ-angers.hal.science/hal-03134628
https://univ-angers.hal.science/hal-03134628